类胰岛素样生长因子1与明胶微球复合物对兔下颌骨缺损愈合影响的实验研究
本文选题:类胰岛素样生长因子1 + 明胶微球 ; 参考:《山西医科大学》2014年硕士论文
【摘要】:目的: 将类胰岛素样生长因子1(Insulin-like growth factors-1, IGF-1)以明胶微球(Gelatinmicrosphere, GMs)为载体缓释剂,形成IGF-1明胶微球复合物,局部应用于兔下颌骨骨缺损处,通过对术后全身血清学及局部形态学和病理学变化的观察,研究IGF-1明胶微球复合物对下颌骨缺损愈合的影响。 方法: 将27只日本成年大耳白兔根据数字随机表法分成3组,各组均在下颌骨体部制作一大小为13mm×6mm×5mm的单侧皮质骨缺损模型,实验组于缺损区植入IGF-1明胶微球复合物,对照组植入吸附生理盐水的空白明胶微球,,空白对照组不做特殊处理。建模前后采耳缘静脉血,通过生化检查观察各组血液中钙、磷和碱性磷酸酶(Alkaline phosphatase,ALP)含量的动态变化;分别于术后4、8、12周每组各处死3只进行大体解剖观察、X线摄片、HE染色和新生骨小梁百分比测定。 结果: 建模成功,术后各组动物均未见明显的免疫排斥反应。 大体标本观察显示:4周时各组都有新生组织生成,但都尚未充满缺损区,且与周围正常骨组织界限清楚,其中实验组探诊时质地稍硬,空白组及对照组探诊时质软。8周时,实验组新骨基本充满缺损区,色泽与周围骨组织基本一致,空白组与对照组可见暗红色骨质充满缺损内,与正常骨组织颜色略有差异。但各组仍可辨别缺损区与周围正常组织界限。12周时,各组骨缺损区基本被新生骨组织修复,颜色、质地与周围骨相近,边界不清。 X线片显示:4周时实验组缺损区边缘不均匀的高密度骨痂影呈云雾状分布,而对照组及空白组骨缺损区边缘密度及范围均明显低于实验组,8周时:各组骨缺损区密度均较4周时明显增高,其中实验组又高于对照组和空白组。12周:实验组骨密度与周围骨组织相近,对照组和空白组稍差,中间可见小范围低密度影。 血清学显示:术后各组碱性磷酸酶值均升高,实验组峰值较对照组和空白组高(p0.05)且其出现时间较早,维持一段时间后逐渐降低,且随着缺损区骨修复的完成逐渐恢复到术前水平;术后2周时各组钙值均呈现升高趋势,实验组高于对照组(p0.05),4周开始钙值逐渐降低,实验组下降较对照组显著(p0.05),到10周时趋于平稳,各组无明显差异,而与钙值相比,磷值呈现相反的趋势。 病理染色显示:实验组骨缺损早期(4周)可见少量不成熟骨小梁和胶原成分形成;缺损8周时,各组均有大量新骨及类骨质形成,实验组不仅可见板层状成熟骨小梁均匀排列,且数量多于对照组;缺损12周时,实验组形成的新骨基本接近成熟,与正常骨质分界不明显。同时不论是4周、8周还是12周时,实验组骨密度及新生骨面积百分比都明显高于对照组和空白组,且差异有统计学意义,而对照组与空白组差异不明显。 结论: 1、实验成功建立了兔下颌骨骨缺损模型。 2、血清ALP、钙值和磷值在不同时间段的差异性变化,可以反应各组不同时期缺损处的成骨情况,提示IGF-1/GMs复合物可能会促进颌骨缺损早期修复。 3、病理学及影像学结果也表明IGF-1/GMs复合物可能促进颌骨缺损早期修复,具有良好的生物相容性,为指导相关的临床研究提供了实验基础。
[Abstract]:Objective:
The insulin like growth factor 1 (Insulin-like growth factors-1, IGF-1) was used as the carrier release agent of Gelatinmicrosphere (Gelatinmicrosphere, GMs) as the carrier release agent to form the IGF-1 gelatin microsphere complex. It was applied locally to the rabbit mandible bone defect. By observing the changes of the whole body serology and the pathological changes of the local department after the operation, the microsphere of IGF-1 gelatin microsphere was studied. The effect of ball complex on the healing of mandibular defect.
Method:
27 adult Japanese white rabbits were divided into 3 groups according to the digital random table method. Each group made a unilateral cortical bone defect model of 13mm x 6mm x 5mm in the mandible body part. The experimental group implanted IGF-1 gelatin microsphere complex in the defect area, and the control group implanted blank gelatin microspheres adsorbed by the saline. The blank control group did not do special treatment. The dynamic changes of calcium, phosphorus and alkaline phosphatase (Alkaline phosphatase, ALP) content in the blood were observed by biochemical examination before and after the modeling, and 3 rats in each group were killed at 4,8,12 weeks after the operation for gross anatomical observation, X-ray photography, HE staining and the percentage of new bone trabecula.
Result:
After successful modeling, no obvious immunological rejection was observed in all animals after operation.
The gross specimen observation showed that there were new tissues in each group at 4 weeks, but all were not full of the defect area, and the boundary of normal bone tissue was clear. In the experimental group, the texture of the experimental group was slightly hard, the blank group and the control group were soft.8 weeks, the new bone in the experimental group was basically full of the loss area, the color and the color and the surrounding bone tissue were basically the same, blank group. In the control group, there was a slight difference between the dark red bone fill defect and the normal bone tissue color. However, the bone defect areas were basically repaired by the new bone tissue at.12 weeks, and the color and texture were close to the surrounding bone, and the boundary was not clear.
The X-ray showed that the density of high density callus in the edge of the defect area in the experimental group was cloudy and foggy at 4 weeks, while the margin density and range of the bone defect area in the control group and the blank group were significantly lower than that of the experimental group. At the 8 week, the density of the bone defects in each group was significantly higher than that of the 4 weeks, and the test group was higher than the control group and the blank group.12 weeks: the experiment was the experiment. The bone mineral density of the group was similar to that of the surrounding bone tissue, while the control group and the blank group were slightly worse.
Serology showed that the alkaline phosphatase of all groups increased after the operation, and the peak value of the experimental group was higher than that of the control group and the blank group (P0.05). It appeared earlier, and gradually decreased after a period of time, and gradually recovered to the preoperative level with the completion of bone repair in the defect area. The calcium values in each group were increased at 2 weeks after the operation, and the experimental group was higher than that in the experimental group. In group (P0.05), the value of calcium decreased gradually at the beginning of the 4 week, the decrease of the experimental group was significantly higher than that of the control group (P0.05), and it tended to be stable at the end of the 10 week, and there was no significant difference in each group, but the phosphorus value showed the opposite trend compared with the calcium value.
Pathological staining showed that a small amount of immature bone trabecula and collagen were formed in the early (4 weeks) bone defect of the experimental group, and a large number of new bone and osteoid were formed at 8 weeks of defect. The experimental group not only showed the lamellar matured trabecula in the experimental group, but also more than the control group. The new bone formed in the experimental group was almost close at 12 weeks, and the new bone formed basically close to the experimental group. At the same time, the percentage of bone mineral density and new bone area in the experimental group was significantly higher than that of the control group and the blank group at the same time of 4 weeks, 8 weeks or 12 weeks, and the difference was statistically significant, but the difference between the control group and the blank group was not obvious.
Conclusion:
1, a rabbit mandibular bone defect model was successfully established.
2, the difference of serum ALP, calcium and phosphorus in different time periods can reflect the osteogenesis of the defects at different stages, suggesting that the IGF-1/GMs complex may promote the early repair of the mandible defect.
3, the results of pathology and imaging also show that IGF-1/GMs complex may promote the early repair of jaw defect and have good biocompatibility, which provides an experimental basis for guiding the related clinical research.
【学位授予单位】:山西医科大学
【学位级别】:硕士
【学位授予年份】:2014
【分类号】:R782.4
【相似文献】
相关期刊论文 前10条
1 李雄伟,严昌虹,王丹青,陈晓理;功能高分子微球研究——~(99m)Tc明胶微球的制备及其动物活体显像[J];生物医学工程学杂志;1991年02期
2 丁红,邢桂琴,谢茵;阿霉素明胶微球的制备与特性研究[J];中国医院药学杂志;2000年07期
3 唐辉,陈文,姚新成,洪成林,陈坚;缓释阿维菌素明胶微球的研制及其体外释放特性[J];中国新药杂志;2002年06期
4 唐辉,洪成林,姚新成,王鲁石,陈坚;双波长法测定阿维菌素明胶微球体外释放中主药含量[J];农垦医学;2002年01期
5 袁敏,田建明,苏国强,王永春,陈炜,郝西彦,蔡希刚;去甲斑蝥素明胶微球肝节段性栓塞的犬实验研究[J];中国中西医结合影像学杂志;2003年01期
6 张自然,陆彬,舒广晔,谢华,易秋艳,贺英菊,王剑红;硫酸链霉素肺靶向明胶微球的研究[J];华西医科大学学报;1995年02期
7 杨云霞,包定元,曾昭贤,何晓,陆彬;肺靶向制剂——硫酸链霉素明胶微球的药理学研究[J];中国抗生素杂志;1998年03期
8 毛世瑞,毕悦,毕殿洲;盐酸尼卡地平鼻粘膜用明胶微球的工艺研究[J];沈阳药科大学学报;2002年02期
9 于宝成;博来霉素明胶微球的制备[J];国外医药.抗生素分册;1987年06期
10 杨艳,包定元;米托蒽醌明胶微球对小鼠肺部S180的作用(英文)[J];泸州医学院学报;1998年02期
相关会议论文 前10条
1 刘捷;王颖;赵惠;张超;刘爱英;汤克勇;;水合力对双醛淀粉交联明胶微球聚集稳定性的影响[A];2011年全国高分子学术论文报告会论文摘要集[C];2011年
2 李桃;杨帆;佃少娜;伍善广;陈颖;刘星辰;傅英梅;;红霉素明胶微球的制备工艺(英文)[A];广东省药学会2009学术年会论文集[C];2010年
3 龙健晶;孙永海;张宏;;吗啡明胶微球体外释放研究及稳定性考察[A];中国(第七届)肿瘤微创治疗学术大会暨世界影像导引下肿瘤微创治疗学会成立筹备大会论文汇编[C];2011年
4 孟庆江;马威;封兴华;;氨甲蝶呤明胶微球的研制及相关生物学特性[A];第五届全国口腔颌面放射学术会议论文汇编[C];2004年
5 刘琼;赵世华;陆敏杰;闫朝武;韦云青;;磁共振评价血管内皮生长因子缓释微球与骨髓间充质干细胞联合移植治疗心肌梗死的疗效[A];中华医学会心血管病学分会第十次全国心血管病学术会议汇编[C];2008年
6 马威;封兴华;于开涛;白振西;;新型平阳霉素明胶微球体内释药特点的研究[A];2004'全国口腔颌面部脉管性疾病学术研讨会论文集[C];2004年
7 龙健晶;孙永海;张宏;;吗啡明胶微球的药物代谢动力学研究[A];中国(第七届)肿瘤微创治疗学术大会暨世界影像导引下肿瘤微创治疗学会成立筹备大会论文汇编[C];2011年
8 罗聪;李明;陈宾;倪滨;江标;;超顺磁性壳聚糖质粒(pAdTRACKBMP9)明胶微球促进骨缺损愈合的初步研究[A];中华医学会第八次全国小儿外科学术会论文集[C];2010年
9 周友中;牛丽娟;肖希龙;;恩诺沙星肺靶向微球在犬体内分布与药物动力学研究[A];中国畜牧兽医学会兽医药理毒理学分会第九次学术讨论会论文与摘要集[C];2006年
10 龙健晶;孙永海;张宏;;吗啡明胶微球的药效学研究[A];中国(第七届)肿瘤微创治疗学术大会暨世界影像导引下肿瘤微创治疗学会成立筹备大会论文汇编[C];2011年
相关重要报纸文章 前2条
1 刘玉梅 张自强;微球制剂研究日益深入[N];中国医药报;2006年
2 王梅 高晓黎;微粒载体给药系统在中药制剂中的应用[N];中国医药报;2004年
相关博士学位论文 前10条
1 王春梅;甲磺酸达氟沙星明胶微球的制备及药动学和肺靶向性研究[D];华中农业大学;2010年
2 刘琼;细胞因子缓释微球联合骨髓间充质干细胞移植治疗缺血性心脏病疗效评价及MRI在体示踪的实验研究[D];中国协和医科大学;2009年
3 葛军;超级电容器用明胶基和化学气相沉积碳材料的研究[D];中国科学院研究生院(理化技术研究所);2009年
4 孙瑞雪;明胶微球和明胶基复合微球的制备与性能研究[D];中国科学院研究生院(理化技术研究所);2009年
5 厉孟;新型多孔自固化人工骨治疗骨质疏松骨缺损的实验研究[D];第四军医大学;2009年
6 马兆峰;牙本质源性蛋白诱导牙周膜干细胞分化及促进牙周再生的实验研究[D];第四军医大学;2008年
7 陆伟;脂肪组织来源干细胞在皮肤与脂肪组织再生中作用的研究[D];第四军医大学;2011年
8 王健;氨基化明胶的性能及在鼻粘膜给药的应用研究[D];沈阳药科大学;2002年
9 晏晓青;应用人脂肪前体细胞构建工程化脂肪组织的实验研究[D];中国协和医科大学;2006年
10 杨家骥;人脐静脉内皮细胞构建血管化组织工程真皮的研究[D];第四军医大学;2008年
相关硕士学位论文 前10条
1 石婧圆;转化生长因子-β_1明胶微球的研制[D];广东药学院;2011年
2 张晓霞;转化生长因子明胶微球的制备及其对人牙周膜细胞增殖作用的影响[D];山西医科大学;2010年
3 郝晓丽;明胶微球的制备及其对阴离子染料的吸附性能研究[D];陕西科技大学;2012年
4 落全祥;类胰岛素样生长因子1与明胶微球复合物对兔下颌骨缺损愈合影响的实验研究[D];山西医科大学;2014年
5 于开涛;平阳霉素明胶微球的研制及其相关生物特性的实验研究[D];第四军医大学;2002年
6 程杰;仙人掌多糖明胶微球的工艺研究[D];湖南农业大学;2013年
7 李玲;rhIGF-I明胶微球的制备及对人牙周膜成纤维细胞作用的实验性研究[D];山西医科大学;2010年
8 马威;5-氟尿嘧啶明胶微球的研制及乙基纤维素微球生物学特性的实验研究[D];第四军医大学;2001年
9 范晶鑫;多拉菌素明胶微球的制备及其在山羊体内药动学研究[D];东北农业大学;2008年
10 王忆娟;作为细胞微载体的明胶缓释微球的制备及其性能研究[D];陕西师范大学;2008年
本文编号:2068636
本文链接:https://www.wllwen.com/yixuelunwen/kouq/2068636.html